Previous studies have demonstrated that administration of the ROCK2 inhibitor fasudil could prevent the reduction in dendritic arbour complexity and loss of dendritic spines in Alzheimer’s disease mice [55], which further consolidated our findings. Here, ROCK2 is linked to Alzheimer disease.